{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:22:47Z","timestamp":1794921767903,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.healun.2026.07.029","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:01:15Z","timestamp":1785283275000},"page":"2020-2027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global approaches to chronic lung allograft dysfunction: Toward evidence-based harmonization"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-9251","authenticated-orcid":false,"given":"Robin","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2026.07.029_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2026.04.001","article-title":"International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2026 Annual Report of Heart and Lung Transplantation.","author":"Dellgren","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.healun.2024.10.013","article-title":"Impact of tacrolimus vs cyclosporine on chronic lung allograft dysfunction incidence and allograft survival in the International Society of Heart and Lung Transplantation registry","volume":"44","author":"Combs","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome-a consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib5","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.healun.2026.02.1677","article-title":"ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): definition, etiology, diagnostic and therapeutic approaches, and research priorities","volume":"45","author":"Juvet","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2026.05.031","article-title":"Baseline lung allograft dysfunction: definition, timing, and implications for outcomes \u2013 an ISHLT consensus document","author":"Gottlieb","year":"2026","journal-title":"J Heart Lung Transplant"},{"issue":"26","key":"10.1016\/j.healun.2026.07.029_bib7","first-page":"01865","article-title":"International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition","author":"Calabrese","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14251","article-title":"Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel","volume":"26","author":"Luong","year":"2024","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2026.07.029_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/phar.2716","article-title":"Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.healun.2026.07.029_bib12","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/j.healun.2025.09.017","article-title":"Considerations for endpoints in lung transplant clinical trials: an ISHLT consensus statement","volume":"45","author":"Greenland","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib13","doi-asserted-by":"crossref","first-page":"00675-2024","DOI":"10.1183\/23120541.00675-2024","article-title":"Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres","volume":"11","author":"Gottlieb","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.healun.2026.07.029_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001897","article-title":"Variability in lung transplant clinical practices in Canada: results of a national survey","volume":"12","author":"Michaels","year":"2026","journal-title":"Transplant Direct"},{"key":"10.1016\/j.healun.2026.07.029_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2026.06.004","article-title":"CF Lung Transplant Initiative Investigators. Approach to prevention and management of chronic lung allograft dysfunction in North American lung transplant centers.","author":"Kapnadak","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ppul.26187","article-title":"Monitoring practices of chronic lung allograft dysfunction in pediatric lung transplantation","volume":"58","author":"Avdimiretz","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.healun.2026.07.029_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100347","article-title":"Worldwide practices in pulmonary function test reporting after lung transplantation","volume":"9","author":"Gottlieb","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2026.07.029_bib18","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.07.029_bib19","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.healun.2020.07.006","article-title":"Bronchoalveolar lavage standardization workgroup. International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation","volume":"39","author":"Martinu","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib20","article-title":"Pathologists' experience and routine practice in high-volume lung transplant centers: an international survey","volume":"11","author":"Calabrese","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2026.07.029_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.healun.2022.06.021","article-title":"Lung allograft standardized histological analysis (LASHA) template: a research consensus proposal","volume":"41","author":"Calabrese","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12445","article-title":"European Society for Organ Transplantation (ESOT) consensus statement on the use of non-invasive biomarkers for cardiothoracic transplant rejection surveillance","volume":"37","author":"Nikolova","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2026.07.029_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.196651","article-title":"Single-cell multi-omic analysis of mesenchymal cells reveals molecular signatures and regulators of lung allograft fibrosis","author":"Lu","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2026.07.029_bib24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ajt.2026.01.025","article-title":"Immune gene correlation networks differentiate both chronic lung allograft dysfunction and survival","volume":"26","author":"Moghbeli","year":"2026","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004725","article-title":"Multi-omics biomarkers of endothelial dysregulation preceding chronic lung allograft dysfunction: a prospective cohort study","volume":"23","author":"Iacono","year":"2026","journal-title":"PLoS Med"},{"key":"10.1016\/j.healun.2026.07.029_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03292-2020","article-title":"Multi-omics profiling predicts allograft function after lung transplantation","volume":"59","author":"Watzenboeck","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.07.029_bib27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.healun.2024.07.010","article-title":"Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality","volume":"43","author":"Mohanty","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib28","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.healun.2022.08.014","article-title":"The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa","volume":"41","author":"Halloran","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02380-2025","article-title":"A transcriptomic atlas of chronic lung allograft dysfunction","author":"Beeckmans","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.07.029_bib30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.healun.2024.04.064","article-title":"Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease","volume":"43","author":"Keller","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2026.01.022","article-title":"Donor-derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: are absolute levels better than percentage?","volume":"45","author":"Phipps","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2026.04.005","article-title":"Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era","author":"Keller","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications.","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.healun.2026.07.029_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":"A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.07.029_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.healun.2020.09.006","article-title":"Azithromycin prophylaxis after lung transplantation is associated with improved overall survival","volume":"39","author":"Li","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.healun.2021.10.008","article-title":"Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation Community","volume":"41","author":"Kapnadak","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-2600(23)00293-X","article-title":"Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial","volume":"12","author":"Dellgren","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2026.07.029_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70016","article-title":"Beyond borders: international immunosuppression practices in pediatric lung transplantation","volume":"38","author":"Wong","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14413","article-title":"Infection Prevention and Treatment Working Group of the LUNG-SITO study group. Infections management in the lung transplant setting in Italy: a web-survey","volume":"27","author":"Lombardi","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2026.07.029_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2024.01.002","article-title":"Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction","volume":"43","author":"Ramendra","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100145","article-title":"Antireflux surgery for prevention of chronic lung allograft dysfunction (CLAD) onset after lung transplantation: the earlier the better before CLAD onset? A single-center series of 284 patients","volume":"6","author":"Hamid","year":"2024","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2026.07.029_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jca.70113","article-title":"Variations in therapeutic plasma exchange and extracorporeal photopheresis practice patterns: survey results from the ASFA solid organ transplantation subcommittee","volume":"41","author":"Lee","year":"2026","journal-title":"J Clin Apher"},{"key":"10.1016\/j.healun.2026.07.029_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14906","article-title":"Current usage of extracorporeal photopheresis in solid organ transplantations in Europe: a narrative review","volume":"38","author":"Cashmore","year":"2025","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2026.07.029_bib44","volume":"11","author":"Fisher","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.healun.2026.07.029_bib45","doi-asserted-by":"crossref","unstructured":"Venkatesan P. GOLD COPD report: 2026 update. Lancet Respir Med. 2025 Nov 26:S2213-2600(25)00432-1. doi: 10.1016\/S2213-2600(25)00432-1.","DOI":"10.1016\/S2213-2600(25)00432-1"},{"key":"10.1016\/j.healun.2026.07.029_bib46","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2026.07.029_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ard.2025.08.021","volume":"85","author":"Antoniou","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.healun.2026.07.029_bib48","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS Scientific Document Group. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2026.07.029_bib49","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2026.0017","article-title":"Non-small cell lung cancer, version 4.2026, NCCN clinical practice guidelines in oncology","volume":"24","author":"Riely","year":"2026","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.healun.2026.07.029_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70094","article-title":"Survey of extracorporeal life support application in lung transplantation","volume":"39","author":"Wilkey","year":"2025","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2026.16295","article-title":"Post-lung transplant surveillance in 2026: current practice, variability, and the need for standardization","volume":"39","author":"Saez-Gimenez","year":"2026","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2026.07.029_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000553086","article-title":"Follow-up care after adult lung transplantation: summary of an evidence-based clinical practice guideline for German-speaking countries","author":"Gottlieb","year":"2026","journal-title":"Respiration"},{"key":"10.1016\/j.healun.2026.07.029_bib53","doi-asserted-by":"crossref","unstructured":"Bos S, Hellemons M, Dave K, et al. European Society for Organ Transplantation Clinical Practice Guideline on Prevention and Treatment of Chronic Lung Allograft Dysfunction. Transplant Int. 2026, in press.","DOI":"10.3389\/ti.2026.16959"},{"key":"10.1016\/j.healun.2026.07.029_bib54","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.healun.2025.06.011","article-title":"Trajectories of FEV1 after lung transplantation and patient outcomes","volume":"44","author":"Raynaud","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib55","doi-asserted-by":"crossref","unstructured":"Neely ML, Wojdyla DM, Hong H, et al. Latent class analysis identifies pulmonary function trajectory phenotypes in lung transplant recipients with chronic allograft dysfunction. medRxiv [Preprint]. 2026 Apr 23:2026.04.22.26351501. doi: 10.64898\/2026.04.22.26351501.","DOI":"10.64898\/2026.04.22.26351501"},{"key":"10.1016\/j.healun.2026.07.029_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s43856-025-00732-x","article-title":"Harnessing deep learning to detect bronchiolitis obliterans syndrome from chest CT","volume":"5","author":"Kozi\u0144ski","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.healun.2026.07.029_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajt.2022.12.019","article-title":"Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death","volume":"23","author":"Keller","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib58","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2020.08.013","article-title":"Molecular T-cell-mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss","volume":"39","author":"Halloran","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib59","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.ajt.2026.02.002","article-title":"Airway molecular signatures in antibody-mediated lung transplant rejection","volume":"26","author":"Mohanty","year":"2026","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib60","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies","volume":"31","author":"Diebold","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2026.07.029_bib61","unstructured":"European Reference Network on Rare Respiratory Diseases (ERN-LUNG). Disease groups: Chronic Lung Allograft Dysfunction (CLAD) [Internet]. ERN-LUNG; 2026 [cited 2026 Jul 16]. Available from: https:\/\/ern-lung.eu\/our-expertise\/disease-groups\/."},{"key":"10.1016\/j.healun.2026.07.029_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajt.16858","article-title":"A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation","volume":"22","author":"Neurohr","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib63","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02154-2024","article-title":"A European multicentre, randomised controlled trial of pirfenidone in bronchiolitis obliterans syndrome after bilateral lung transplantation","volume":"67","author":"Perch","year":"2026","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.07.029_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2026.03.032","article-title":"The ASSIST CLAD study: a phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction","author":"Chambers","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13063-025-09314-7","article-title":"INFINITIx-BOS Consortium. Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial","volume":"27","author":"Brugi\u00e8re","year":"2026","journal-title":"Trials"},{"key":"10.1016\/j.healun.2026.07.029_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.healun.2019.02.004","article-title":"Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices","volume":"38","author":"Goldstein","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100349","article-title":"Priorities for lung transplantation research: a James Lind Alliance priority-setting partnership between patients, caregivers, and clinicians in Canada","volume":"9","author":"Michaels","year":"2025","journal-title":"JHLT Open"},{"key":"10.1016\/j.healun.2026.07.029_bib68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.healun.2025.11.023","article-title":"Lung Transplant Consortium Investigators and Steering Committee. The NHLBI lung transplant consortium 2025 steering committee report: Strategies to maximize the use of the consortium for advancing lung transplantation","volume":"45","author":"Neely","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2026.07.029_bib69","unstructured":"International Society for Heart and Lung Transplantation. Protecting the Research Enterprise That Advances Thoracic Transplantation and Patient Care. Chicago (IL): International Society for Heart and Lung Transplantation; 2026. Available from: ISHLT Statement: Protecting the Research Enterprise That Advances Thoracic Transplantation and Patient Care. https:\/\/www.ishlt.org\/about\/news-detail\/2026\/07\/13\/ishlt-issues-statement-on-protecting-the-research-enterprise-that-advances-thoracic-transplantation-and-patient-care?utm_source=chatgpt.com."}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826020140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826020140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:10:48Z","timestamp":1794921048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249826020140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1053249826020140"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.07.029","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global approaches to chronic lung allograft dysfunction: Toward evidence-based harmonization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}